Skip to main content

Carbamazepine

NDC 60505-2807 · Apotex Corp.

Generic nameCarbamazepine
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength300 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryANDA

Packages

60505-2807-7 — 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-2807-7)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60290-008 — Carbamazepine, 60290-034 — Carbamazepine, 60290-058 — Carbamazepine, 60290-059 — Carbamazepine, 60290-060 — Carbamazepine, 60429-032 — CARBAMAZEPINE, 60429-934 — Carbamazepine, 60505-0183 — CARBAMAZEPINE, 60505-2805 — Carbamazepine, 60505-2806 — Carbamazepine, 60687-479 — Carbamazepine, 60687-583 — CARBAMAZEPINE, 60687-594 — CARBAMAZEPINE, 62135-802 — Carbamazepine, 62135-867 — Carbamazepine, 62135-927 — Carbamazepine ER, 62135-928 — Carbamazepine ER, 62135-930 — Carbamazepine ER, 62332-420 — Carbamazepine, 62332-421 — Carbamazepine, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.